Cell & Gene Therapy Innovation Speaker
Dr. Pavlina Konstantinova is Vice President Research at uniQure, a gene therapy company focusing on orphan genetic diseases including HD. She has obtained MSc and PhD in Molecular Biology at Sofia university, Bulgaria. Dr. K did Postdoc at the Academic Medical Center, Amsterdam on HIV-1 and at Duke University Medical center, NC on KSHV-encoded miRNAs. She is with uniQure for almost 10 years, working on RNAi gene therapy for CNS and liver indications and started the HD project at the company.